2016
DOI: 10.2147/plmi.s56781
|View full text |Cite
|
Sign up to set email alerts
|

Multiparametric autoimmune diagnostics: recent advances

Abstract: Autoimmune diagnostics in a routine clinical laboratory is constantly challenged by the discovery of new autoantibodies and technical innovations in the immunoassays applied. These challenges are, in particular, combined in the multiparametric immunoassays. Appropriate positioning of multiparametric immunoassays within the laboratory requires integrated knowledge of the clinical performance of the test system for each individual antigen, the conditions prescribed in disease criteria and/or guidelines, and the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 47 publications
(67 reference statements)
0
5
0
Order By: Relevance
“…Patients who suffer from autoimmune diseases of the gastrointestinal tract may also benefit from the multiparametric detection of autoantibodies. These diseases include autoimmune gastritis, pernicious anemia, autoimmune hepatitis, primary biliary cirrhosis and CD [ 24 ]. Presented in the current study, the simultaneous detection of serological CD markers with tIgA can reduce not only the costs of serological CD diagnosis compared to single celiac-specific antibody detection and tIgA but may also shorten CD diagnostic process.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients who suffer from autoimmune diseases of the gastrointestinal tract may also benefit from the multiparametric detection of autoantibodies. These diseases include autoimmune gastritis, pernicious anemia, autoimmune hepatitis, primary biliary cirrhosis and CD [ 24 ]. Presented in the current study, the simultaneous detection of serological CD markers with tIgA can reduce not only the costs of serological CD diagnosis compared to single celiac-specific antibody detection and tIgA but may also shorten CD diagnostic process.…”
Section: Discussionmentioning
confidence: 99%
“…It is worth noting that the test we analyzed provided quantitative results, which is beneficial for diagnosis, follow-up and therapy of CD and many other autoimmune diseases. It is even more important that not all multiparametric immunoassays provide us with quantitative results [ 24 ]. An example of immunofluorassay used to detect simultaneously celiac-specific antibodies and tIgA, such as Polycheck ® Celiac IgA plus Total IgA, is CytoBead CeliAK (GA Generic Assays GmbH, Dahlewitz, Germany), which is performed with fluorescent microparticles for antigen and antibody immobilization, and monkey-esophagus tissue.…”
Section: Discussionmentioning
confidence: 99%
“…On one hand, new autoantibodies are constantly being discovered, and on the other hand-the immunoassays innovate technically every year. The challenges rice when autoantibody testing is combined in the multiparametric immunoassays [9]. Appropriate positioning of each individual antigen in the multiparametric immunoassays requires integrated knowledge of the disease criteria (grounded in the certain guidelines and consensuses), which defines also the clinical performance of the whole test system.…”
Section: Discussionmentioning
confidence: 99%
“…Appropriate positioning of each individual antigen in the multiparametric immunoassays requires integrated knowledge of the disease criteria (grounded in the certain guidelines and consensuses), which defines also the clinical performance of the whole test system. However, the usefulness and the up keeping of the multiparametric immunoassays in the laboratory depends on the demands of the clinicians [9]. Here, we tested patients with autoimmune liver disease for the presence of different autoantibodies, by means of the gold standard IIF, as well as by line blot immunoassay for simultaneous detection of nine distinct autoantibodies.…”
Section: Discussionmentioning
confidence: 99%
“…[4][5][6] However, in cases where identification of multiple antibodies is relevant for a diseases circle (such as ABDs), screening by multiplex test, allowing analysis in a single test run, is considered as an efficient diagnostic first step. Technical innovation of immunoassays aimed at multiplex approach, 7 like IIF multiplex biochip [8][9][10] and multivariant profile ELISA. [11][12][13][14][15] Most recently, two multiparametric ELISA tests are commercially available (Euroimmun, Germany; MBL, Nagoya, Japan) for ABDs serology.…”
Section: Introductionmentioning
confidence: 99%